You sure about all this mal?
MedAdvisor has been around for a number of years before listing on the ASX.
Yes, there are other apps which have been built in-house by hospitals, GPs and Pharmacies but none have the integration and support from big pharma (Arrow, GSK, Bristol-Myers Squibb), organisations/foundations (Epilepsy, PainAustralia) and private healthcare (Bupa). If you compare the apps out there they are buggy, lack features and are built 'cheap' for the niche segment (Hospital A, GP B and Pharmacy C). Take a look at the market share of the big pharma who have thrown their support behind MDR.
Obviously GPLink won't be suitable for every condition or patient, but there are a large majority of appointments that could be 'treated/assessed/repeat scripts issued' without booking an $80 face-to-face.
MDR Charting, page-209
-
- There are more pages in this discussion • 110 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $215.0M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 27.5¢ | $254.8K | 889.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39326 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 2917 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MDR (ASX) Chart |
